Health Report: Jul. 26, 1993


The FDA has approved a new drug for treating the terrible suffering caused when breast or prostate cancer spreads to the bone. Called Metastron, the drug kills the pain of the cancer (though not the cancer) with radioactive strontium-89 delivered by injection. Metastron works better than narcotics for many patients, and a single shot lasts up to six months.

Researchers in Germany and the U.S. think they're homing in on a cause of dyslexia, the brain abnormality that makes language processing -- especially reading the printed word -- difficult for about 3% of the population. At least some...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!